Common Contracts

4 similar Common Stock Purchase Agreement contracts by Exicure, Inc.

COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • February 21st, 2025 • Exicure, Inc. • Pharmaceutical preparations • Delaware

This Common Stock Purchase Agreement (the “Agreement”), dated as of February 14, 2025, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Schedule 1 hereto or an Affiliate thereof (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.6.

COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • December 11th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Delaware

This Common Stock Purchase Agreement (the “Agreement”), dated as of December 9, 2024, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Schedule 1 hereto or an Affiliate thereof (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.6.

COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • November 14th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Delaware

This Common Stock Purchase Agreement (the “Agreement”), dated as of November [13], 2024, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Schedule 1 hereto (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.6.

COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • November 14th, 2024 • Exicure, Inc. • Pharmaceutical preparations • Delaware

This Common Stock Purchase Agreement (the “Agreement”), dated as of November 6, 2024, by and among Exicure, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Schedule 1 hereto (each, including its successors and assigns, a “Purchaser” and together, the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5.